1.71
0.05 (3.01%)
| Penutupan Terdahulu | 1.66 |
| Jumlah Dagangan | 8,241 |
| Harga / Jualan (P/S) | 29.32 |
| Harga / Buku (P/B) | 0.240 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -7,855.96% |
| EPS Cair (TTM) | -11.50 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 87.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 47.32% |
| Nisbah Semasa (MRQ) | 21.68 |
| Aliran Tunai Operasi (OCF TTM) | -5.54 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.35 M |
| Pulangan Atas Aset (ROA TTM) | -35.44% |
| Pulangan Atas Ekuiti (ROE TTM) | -72.53% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Bercampur | Menurun |
| Health Information Services (Global) | Bercampur | Menurun | |
| Stok | Aclarion, Inc. | Bercampur | Menaik |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ACON | - | - | - | 0.240 |
| STRM | 23 M | - | - | 2.10 |
| ICCT | 8 M | - | - | 8.91 |
| MGRX | - | - | - | 0.310 |
| HCAT | - | - | - | 1.18 |
| ZCMD | - | - | - | 0.010 |
AISkor Stockmoo
| Nilai 35% | -0.4 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -0.4 |
| Masa 35% | -0.5 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.5 |
| Purata Bergerak Teknikal info | 2.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Sentimen Berita info | NA |
| Persekitaran | ×1.07 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | +12.2% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 1.1 |
| Skor Akhir | -0.34 |
|
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Institusi | 0.08% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |